Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.36
-0.52 (-1.93%)
Feb 11, 2026, 3:04 PM EST - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
ZORYVE Cream 0.3% Revenue
112.31M85.08M29.19M
ZORYVE Cream 0.3% Revenue Growth
32.00%191.52%691.81%
ZORYVE Foam Revenue
150.37M71.54M-
ZORYVE Foam Revenue Growth
110.19%--
ZORYVE Cream 0.15% Revenue
51.25M9.92M-
ZORYVE Cream 0.15% Revenue Growth
416.60%--
Total Product Revenue
313.93M166.54M29.19M
Total Product Revenue Growth
88.50%470.62%691.81%
Other Segment Revenue
-30.00M30.42M
Other Segment Revenue Growth
--1.38%-
Revenue (Other)
4.00M--
Revenue (Total)
317.93M196.54M59.61M
Revenue (Total) Growth
61.76%229.73%1517.09%
Updated Oct 28, 2025. Data Source: Fiscal.ai.